Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxcyte, Inc.

45.28
+0.53001.18%
Post-market: 45.280.00000.00%16:31 EDT
Volume:1.39M
Turnover:62.50M
Market Cap:5.88B
PE:-10.97
High:45.36
Open:44.30
Low:43.78
Close:44.75
52wk High:116.00
52wk Low:27.66
Shares:129.82M
Float Shares:116.97M
Volume Ratio:1.17
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1261
EPS(LYR):-3.8028
ROE:-21.65%
ROA:-16.44%
PB:1.91
PE(LYR):-11.91

Loading ...

Sep 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Correspondence

Form CORRESP - Correspondence
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities